Channel Therapeutics Corporation (CHRO)
Jul 2, 2025 - CHRO was delisted (reason: merged into PTHS)
13.50
0.00 (0.00%)
Inactive · Last trade price
on Jul 1, 2025
Channel Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Channel Therapeutics.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Channel Therapeutics.
Recommendation Trends
Rating | Jun '24 |
---|---|
Strong Buy | 0 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.12
from -1.43
EPS Next Year
-1.12
from -1.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.